Skip to content
A345Assembly2021-2022 Session

Opioid Bottles Must Warn

Official title

“Relates to labeling prescription bottles of opioids”

Sponsor Edward BraunsteinAD-26+1 co-sponsorAffects Health
Status
In Assembly Committee
Health
Impact
3/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires opioid prescription bottles in New York to have a warning label stating the drug is highly addictive.

Why it matters

  1. Raises immediate awareness for patients and caregivers. By mandating a clear, prominent warning about addiction risks on opioid prescription bottles, this law aims to ensure that anyone handling the medication is directly informed about its potential dangers—potentially prompting more caution or questions before use.

  2. Empowers patients to seek more information. The required label not only warns of addiction but explicitly encourages patients to consult their pharmacist or physician, which could foster more informed discussions about alternatives, safe usage, or the risks of misuse.

  3. Could influence prescribing and dispensing behavior. With the warning label prominently displayed, healthcare providers and pharmacists may be more likely to reinforce conversations about opioid risks, safe storage, and disposal, which could help curb misuse and diversion within households.

  4. Part of a broader public health strategy to address opioid misuse. This measure adds a visible, consistent layer of prevention to existing regulations, supporting broader efforts in New York to reduce opioid addiction rates and associated harms.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Opioid Bottles Must Warn

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Edward Braunstein

Assembly Member · Assembly District 26

Chair, Corporations, Authorities and Commissions

1 Co-sponsor

History

  1. Referred to health
  2. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

345

2021-2022 Regular Sessions

IN ASSEMBLY (Prefiled)

January 6, 2021

Introduced by M. of A. BRAUNSTEIN -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 2 of section 3333 of the public health law is amended by adding a new paragraph (d) to read as follows:

(d) In addition to the other requirements of this subdivision, where the controlled substance being dispensed is an opioid, there shall be affixed to the container a label upon which is indelibly typed, printed, or otherwise legibly written "Warning. This drug is highly addictive. Please consult your pharmacist or physician before using."

§ 2. This act shall take effect on the ninetieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03393-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.